Ovarian cancer ‘invasion cells’ identified

By Hudson Institute communications

Highly mobile, invasive ovarian cancer cells called ‘leader cells’ have been identified as leading the attack on healthy tissue.

Feature video | Dr Maree Bilandzic explains this pivotal discovery, published in Cancers, and the significance of leader cells in finding more effective therapies for ovarian cancer.

Collaborators | Monash University, Bruker Biosciences Pty Ltd, Monash Health, RMIT University

Funders | Contributing to Australian Scholarship in Science (CASS) foundation, Ovarian Cancer Research Foundation, Victorian Government’s Operational Infrastructure Support Program

Contact us

Hudson Institute communications
t: + 61 3 8572 2697
e: communications@hudson.org.au

About Hudson Institute

Hudson Institute’ s research programs deliver in five areas of medical need – inflammation, cancer, reproductive health, newborn health, and hormones and health. More

Hudson News

Get the inside view on discoveries and patient stories

“Thank you Hudson Institute researchers. Your work brings such hope to all women with ovarian cancer knowing that potentially women in the future won't have to go through what we have!”

Alana Chantry